Using Switchable Mouse Genetics to Find the Best Targets for Cancer Treatment
Table of Contents
Gerard Evan - University of Cambridge
Oct 18, 2012
11:00 DKFZ Auditorium
Host: Bruce Edgar
Biosketch Gerard Evan
Gerard Evan received his BA in Biochemistry from the University of Oxford (St. Peter’s College) in 1977 and his PhD in Molecular Immunology in 1981 from the University of Cambridge (King’s College). He was then, first, a Medical Research Council Post-Doctoral Fellow and, second, a Science and Engineering Research Council Post-Doctoral Fellow in the laboratory of J. Michael Bishop at the University of California, San Francisco (UCSF) from 1982-84. In 1984 he returned to the UK to become an Assistant Member of the Cambridge Branch of the Ludwig Institute for Cancer Research and a Research Fellow of Downing College, University of Cambridge. In 1988 he joined the Imperial Cancer Research Fund (ICRF) Laboratories in London as a Senior Scientist (1988-90) and then Principal Scientist from 1990-1999. He was awarded the Pfizer prize in Biology in 1995, and in 1996 was elected as the Royal Society’s Napier Professor of Cancer Research. In 1999 he was elected a Fellow of the UK Academy of Medical Sciences and later that year appointed to the Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Biology at the University of California, San Francisco. He was elected to the Royal Society in 2004, to the Neal Levitan Research Chair of the Brain Tumor Society and, in 2006, became a Senior Scholar of the Ellison Medical Research Foundation for Aging. In 2009, he was elected to the Sir William Dunn chair of Biochemistry in the University of Cambridge.